T 0045/12 (Combination of pioglitazone and glimepiride for treating diabetes/TAKEDA) of 09.11.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T004512.20151109
- Date of decision
- 9 November 2015
- Case number
- T 0045/12
- Petition for review of
- -
- Application number
- 01203170.4
- IPC class
- A61K 31/64A61K 31/4439
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical composition comprising pioglitazone and glimepiride for use in treatment of diabetes
- Applicant name
- Takeda Pharmaceutical Company Limited
- Opponent name
- Laboratorios CINFA, S.A.
Teva Pharmaceutical Industries Ltd. - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)
- Keywords
- Main request - allowable (yes)
- Catchword
- -
- Citing cases
- T 2156/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of the main request filed with the letter of 24 September 2015 together with the description as amended during the oral proceedings before the board.